Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Medications for Wound Healing
Remedor Biomedis a wound healing clinical research stage biopharmaceutical company that develops medications for skin wounds that do not respond well to current treatment options. The company's technology platform is based on a formulation containing a naturally occurring glycoprotein, erythropoietin, which is active in each phase of the healing process.
The company focuses on complex wounds such as diabetic foot ulcer and deep burn wounds. Its cutting-edge innovation is a unique proprietary topical biologic technology platform based on a smart hydrogel-matrix that withstands extreme temperature fluctuations and delivers the active substance on the wound bed effectively.
Identity
| Name | Remedor Biomed |
|---|---|
| Slug | remedor-biomed |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6s38MIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Nof HaGalil |
| HQ address | Ha-Avoda St 12, Nof HaGalil, Israel |
Web & social
| Website | https://www.remedor.com/ |
|---|---|
| https://www.linkedin.com/company/9166050 | |
| https://www.facebook.com/remedorbiomed |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business models
B2B
Tags
ulcerstissue-regenerationregenerative-medicinediabetestopical-treatmentbiopharmaceuticalpharmaceuticalschronic-patientspharma-companiestype-2-diabetes
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}